Literature DB >> 30111562

Acute-Phase CD4+ T Cell Responses Targeting Invariant Viral Regions Are Associated with Control of Live Attenuated Simian Immunodeficiency Virus.

Matthew S Sutton1, Amy Ellis-Connell1, Ryan V Moriarty2, Alexis J Balgeman1, Dane Gellerup2, Gabrielle Barry2, Andrea M Weiler2, Thomas C Friedrich2,3, Shelby L O'Connor4,2.   

Abstract

We manipulated SIVmac239Δnef, a model of major histocompatibility complex (MHC)-independent viral control, to evaluate characteristics of effective cellular responses mounted by Mauritian cynomolgus macaques (MCMs) that express the M3 MHC haplotype, which has been associated with poor control of pathogenic simian immunodeficiency virus (SIV). We created SIVΔnef-8x to test the hypothesis that effective SIV-specific T cell responses targeting invariant viral regions can emerge in the absence of immunodominant CD8+ T cell responses targeting variable epitopes and that control is achievable in individuals lacking known "protective" MHC alleles. Full-proteome gamma interferon (IFN-γ) enzyme-linked immunospot (ELISPOT) assays identified six newly targeted immunogenic regions following SIVΔnef-8x infection of M3/M3 MCMs. We deep sequenced circulating virus and found that four of the six newly targeted regions rarely accumulated mutations. Six animals infected with SIVΔnef-8x had T cell responses that targeted at least one of the four invariant regions and had a lower set point viral load than two animals that did not have T cell responses that targeted any invariant regions. We found that MHC class II molecules restricted all four of the invariant peptide regions, while the two variable regions were restricted by MHC class I molecules. Therefore, in the absence of immunodominant CD8+ T cell responses that target variable regions during SIVmac239Δnef infection, individuals without protective MHC alleles developed predominantly CD4+ T cell responses specific for invariant regions that may improve control of virus replication. Our results provide some evidence that antiviral CD4+ T cells during acute SIV infection can contribute to effective viral control and should be considered in strategies to combat HIV infection.IMPORTANCE Studies defining effective cellular immune responses to human immunodeficiency virus (HIV) and SIV have largely focused on a rare population that express specific MHC class I alleles and control virus replication in the absence of antiretroviral treatment. This leaves in question whether similar effective immune responses can be achieved in the larger population. The majority of HIV-infected individuals mount CD8+ T cell responses that target variable viral regions that accumulate high-frequency escape mutations. Limiting T cell responses to these variable regions and targeting invariant viral regions, similar to observations in rare "elite controllers," may provide an ideal strategy for the development of effective T cell responses in individuals with diverse MHC genetics. Therefore, it is of paramount importance to determine whether T cell responses can be redirected toward invariant viral regions in individuals without protective MHC alleles and if these responses improve control of virus replication.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  CD4+ T cells; CD8+ T cells; Mauritian cynomolgus macaque; invariant epitope; live attenuated SIV; variable epitope

Mesh:

Substances:

Year:  2018        PMID: 30111562      PMCID: PMC6189504          DOI: 10.1128/JVI.00830-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Transcriptionally abundant major histocompatibility complex class I alleles are fundamental to nonhuman primate simian immunodeficiency virus-specific CD8+ T cell responses.

Authors:  Melisa L Budde; Jennifer J Lhost; Benjamin J Burwitz; Ericka A Becker; Charles M Burns; Shelby L O'Connor; Julie A Karl; Roger W Wiseman; Benjamin N Bimber; Guang Lan Zhang; William Hildebrand; Vladimir Brusic; David H O'Connor
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.

Authors:  Xintao Hu; Antonio Valentin; Frances Dayton; Viraj Kulkarni; Candido Alicea; Margherita Rosati; Bhabadeb Chowdhury; Rajeev Gautam; Kate E Broderick; Niranjan Y Sardesai; Malcolm A Martin; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  J Immunol       Date:  2016-10-12       Impact factor: 5.422

3.  HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome.

Authors:  Damien Z Soghoian; Heiko Jessen; Michael Flanders; Kailan Sierra-Davidson; Sam Cutler; Thomas Pertel; Srinika Ranasinghe; Madelene Lindqvist; Isaiah Davis; Kimberly Lane; Jenna Rychert; Eric S Rosenberg; Alicja Piechocka-Trocha; Abraham L Brass; Jason M Brenchley; Bruce D Walker; Hendrik Streeck
Journal:  Sci Transl Med       Date:  2012-02-29       Impact factor: 17.956

4.  Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.

Authors:  C S Hung; N Vander Heyden; L Ratner
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  Mamu-B*08-positive macaques control simian immunodeficiency virus replication.

Authors:  John T Loffredo; Jess Maxwell; Ying Qi; Chrystal E Glidden; Gretta J Borchardt; Taeko Soma; Alex T Bean; Dominic R Beal; Nancy A Wilson; William M Rehrauer; Jeffrey D Lifson; Mary Carrington; David I Watkins
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

6.  Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques.

Authors:  Laura E Valentine; John T Loffredo; Alex T Bean; Enrique J León; Caitlin E MacNair; Dominic R Beal; Shari M Piaskowski; Yann C Klimentidis; Simon M Lank; Roger W Wiseman; Jason T Weinfurter; Gemma E May; Eva G Rakasz; Nancy A Wilson; Thomas C Friedrich; David H O'Connor; David B Allison; David I Watkins
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

7.  Conditional CD8+ T cell escape during acute simian immunodeficiency virus infection.

Authors:  Shelby L O'Connor; Ericka A Becker; Jason T Weinfurter; Emily N Chin; Melisa L Budde; Emma Gostick; Michael Correll; Michael Gleicher; Austin L Hughes; David A Price; Thomas C Friedrich; David H O'Connor
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

8.  Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.

Authors:  Pratima Kunwar; Natalie Hawkins; Warren L Dinges; Yi Liu; Erin E Gabriel; David A Swan; Claire E Stevens; Janine Maenza; Ann C Collier; James I Mullins; Tomer Hertz; Xuesong Yu; Helen Horton
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

9.  CD8+ and CD4+ cytotoxic T cell escape mutations precede breakthrough SIVmac239 viremia in an elite controller.

Authors:  Benjamin J Burwitz; Juan Pablo Giraldo-Vela; Jason Reed; Laura P Newman; Alexander T Bean; Francesca A Nimityongskul; Philip A Castrovinci; Nicholas J Maness; Enrique J Leon; Richard Rudersdorf; Jonah B Sacha
Journal:  Retrovirology       Date:  2012-11-06       Impact factor: 4.602

10.  Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection.

Authors:  Louis J Picker; Shoko I Hagen; Richard Lum; Edward F Reed-Inderbitzin; Lyn M Daly; Andrew W Sylwester; Joshua M Walker; Don C Siess; Michael Piatak; Chenxi Wang; David B Allison; Vernon C Maino; Jeffrey D Lifson; Toshiaki Kodama; Michael K Axthelm
Journal:  J Exp Med       Date:  2004-11-15       Impact factor: 14.307

View more
  6 in total

1.  Acute-Phase CD4+ T Cell Responses Targeting Invariant Viral Regions Are Associated with Control of Live Attenuated Simian Immunodeficiency Virus.

Authors:  Matthew S Sutton; Amy Ellis-Connell; Ryan V Moriarty; Alexis J Balgeman; Dane Gellerup; Gabrielle Barry; Andrea M Weiler; Thomas C Friedrich; Shelby L O'Connor
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

2.  CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency Virus.

Authors:  Matthew S Sutton; Amy Ellis-Connell; Alexis J Balgeman; Gabrielle Barry; Andrea M Weiler; Scott J Hetzel; Yan Zhou; Annie W Lau-Kilby; Rosemarie D Mason; Kristin K Biris; John R Mascola; Nancy J Sullivan; Mario Roederer; Thomas C Friedrich; Shelby L O'Connor
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

3.  Characterization of major histocompatibility complex-related molecule 1 sequence variants in non-human primates.

Authors:  Amy L Ellis-Connell; Nadean M Kannal; Alexis J Balgeman; Shelby L O'Connor
Journal:  Immunogenetics       Date:  2018-10-23       Impact factor: 2.846

4.  Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.

Authors:  Neil Almond; Neil Berry; Richard Stebbings; Mark Preston; Claire Ham; Mark Page; Debbie Ferguson; Nicola Rose; Bo Li; Edward T Mee; Mark Hassall; Christiane Stahl-Hennig; Takis Athanasopoulos; Timos Papagatsias; Shanthi Herath; Adel Benlahrech; George Dickson; Andrea Meiser; Steven Patterson
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

5.  The mucosal barrier and anti-viral immune responses can eliminate portions of the viral population during transmission and early viral growth.

Authors:  Ryan V Moriarty; Athena E Golfinos; Dane D Gellerup; Hannah Schweigert; Jaffna Mathiaparanam; Alexis J Balgeman; Andrea M Weiler; Thomas C Friedrich; Brandon F Keele; Miles P Davenport; Vanessa Venturi; Shelby L O'Connor
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.752

6.  Loss of tetherin antagonism by Nef impairs SIV replication during acute infection of rhesus macaques.

Authors:  Aidin Tavakoli-Tameh; Sanath Kumar Janaka; Katie Zarbock; Shelby O'Connor; Kristin Crosno; Saverio Capuano; Hajime Uno; Jeffrey D Lifson; David T Evans
Journal:  PLoS Pathog       Date:  2020-04-17       Impact factor: 7.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.